Clinical trials
Hypertension trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
214 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 10 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 14 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 13 |
| 2015 | 6 |
| 2016 | 9 |
| 2017 | 13 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 8 |
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 13 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 127 |
| Unknown status | 26 |
| Terminated | 24 |
| Recruiting | 22 |
| Active, not recruiting | 7 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 11 |
| Queen Mary University of London | 9 |
| Cambridge University Hospitals NHS Foundation Trust | 7 |
| Imperial College London | 7 |
| St George's, University of London | 7 |
| University of Edinburgh | 7 |
| Medtronic Vascular | 6 |
| University of Oxford | 6 |
| Alnylam Pharmaceuticals | 5 |
| Boehringer Ingelheim | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 214 |
| Cardiovascular Diseases | 32 |
| Vascular Diseases | 18 |
| Diabetes Mellitus | 16 |
| Renal Insufficiency, Chronic | 15 |
| Diabetes Mellitus, Type 2 | 10 |
| Obesity | 9 |
| Essential Hypertension | 8 |
| Stroke | 8 |
| Heart Failure | 7 |
Trials
Showing 1 to 25 of 214. Each trial links to its page on Pharma Observatory.
114 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.